Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction (MARCI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02673268
Recruitment Status : Recruiting
First Posted : February 3, 2016
Last Update Posted : October 12, 2017
Sponsor:
Information provided by (Responsible Party):
Gustave Roussy, Cancer Campus, Grand Paris

Brief Summary:

The objective of this study is to demonstrate the feasibility of a mastectomy with conservation of the areola using axillary way only with the Da Vinci Robot Xi and immediate breast reconstruction using prosthesis.

The interest is to avoid scars on the breast. The scars are limited to the armpit and under the arm.

The aim is also to study the rate of complications, cosmetic results and quality of life.


Condition or disease Intervention/treatment Phase
Breast Cancer Procedure: Mastectomy Device: Da Vinci Robot Xi Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction
Actual Study Start Date : November 25, 2015
Estimated Primary Completion Date : November 2019
Estimated Study Completion Date : November 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Patients with breast cancer Procedure: Mastectomy
Device: Da Vinci Robot Xi



Primary Outcome Measures :
  1. Rate of necrosis [ Time Frame: Assessed up to 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

1 .Patients with an indication of mastectomy with areola conservation 2. In case of carcinologic surgery:

  • Disease located more than 2cm of the areola on the clinical and paraclinical evaluation
  • Patients with indication of total mastectomy
  • Patients looking for immediate reconstruction 3. In case of prophylactic surgery
  • Patients wishing a prophylactic surgery because of highly risked mutation (BRCA1, BRCA2....) 4. Cup A, B or C maximum 5. Aged between 18 and 70 years old 6. OMS 0, 1 7. Signed informed consent 8. Patients affiliated to a social security system

Exclusion Criteria:

  1. Patients with a high risk of skin necrosis
  2. Planned post operative radiotherapy
  3. Patients with an historic of breast surgery on the side that needs to be operated
  4. Pregnant or breastfeeding women
  5. Persons deprived of liberty
  6. Persons not able to undergo medical follow up due to geographical, social or psychic reasons

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02673268


Contacts
Layout table for location contacts
Contact: Benjamin Sarfati, MD 0142114384 ext +33 Benjamin.sarfati@gustaveroussy.fr
Contact: Stefan Michels, PhD Stefan.michiels@gustaveroussy.fr

Locations
Layout table for location information
France
Gustave Roussy Cancer Campus Recruiting
Villejuif, Val de Marne, France, 94805
Contact: Benjamin Sarfati, MD       Benjamin.sarfati@gustaveroussy.fr   
Contact: Stefan Michiels, PhD       Stefan.michiels@gustaveroussy.fr   
Sponsors and Collaborators
Gustave Roussy, Cancer Campus, Grand Paris

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Gustave Roussy, Cancer Campus, Grand Paris
ClinicalTrials.gov Identifier: NCT02673268     History of Changes
Other Study ID Numbers: 2015-A00745-44
2015/2250 ( Other Identifier: CSET number )
First Posted: February 3, 2016    Key Record Dates
Last Update Posted: October 12, 2017
Last Verified: October 2017